169 related articles for article (PubMed ID: 15771237)
1. A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.
Bachmeier CJ; Miller DW
Pharm Res; 2005 Jan; 22(1):113-21. PubMed ID: 15771237
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.
Bachmeier CJ; Spitzenberger TJ; Elmquist WF; Miller DW
Pharm Res; 2005 Aug; 22(8):1259-68. PubMed ID: 16078135
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
Miller DW; Hinton M; Chen F
Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715
[TBL] [Abstract][Full Text] [Related]
4. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
5. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells.
Huai-Yun H; Secrest DT; Mark KS; Carney D; Brandquist C; Elmquist WF; Miller DW
Biochem Biophys Res Commun; 1998 Feb; 243(3):816-20. PubMed ID: 9500978
[TBL] [Abstract][Full Text] [Related]
7. Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption.
Miller DW; Batrakova EV; Waltner TO; Alakhov VYu ; Kabanov AV
Bioconjug Chem; 1997; 8(5):649-57. PubMed ID: 9327127
[TBL] [Abstract][Full Text] [Related]
8. Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers.
Fontaine M; Elmquist WF; Miller DW
Life Sci; 1996; 59(18):1521-31. PubMed ID: 8890933
[TBL] [Abstract][Full Text] [Related]
9. Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells.
Batrakova EV; Han HY; Miller DW; Kabanov AV
Pharm Res; 1998 Oct; 15(10):1525-32. PubMed ID: 9794493
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
11. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
[TBL] [Abstract][Full Text] [Related]
12. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
13. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
Bachmeier CJ; Trickler WJ; Miller DW
J Pharm Sci; 2004 Apr; 93(4):932-42. PubMed ID: 14999730
[TBL] [Abstract][Full Text] [Related]
14. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
[TBL] [Abstract][Full Text] [Related]
15. Effect of heat preconditioning on the uptake and permeability of R123 in brain microvessel endothelial cells during mild heat treatment.
Ng KY; Cho CW; Henthorn TK; Tanguay RL
J Pharm Sci; 2004 Apr; 93(4):896-907. PubMed ID: 14999727
[TBL] [Abstract][Full Text] [Related]
16. Application of a high-resolution in vitro human MDR1-MDCK assay and in vivo studies in preclinical species to improve prediction of CNS drug penetration.
Jiang L; Kumar S; Nuechterlein M; Reyes M; Tran D; Cabebe C; Chiang P; Reynolds J; Carrier S; Sun Y; Eddershaw P; Hay T; Chen W; Feng B
Pharmacol Res Perspect; 2022 Feb; 10(1):e00932. PubMed ID: 35156331
[TBL] [Abstract][Full Text] [Related]
17. EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.
Meijer DK; Lennernäs H
Eur J Pharm Sci; 2005 Sep; 26(1):130-43. PubMed ID: 16161216
[No Abstract] [Full Text] [Related]
18. Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?
Berezowski V; Landry C; Lundquist S; Dehouck L; Cecchelli R; Dehouck MP; Fenart L
Pharm Res; 2004 May; 21(5):756-60. PubMed ID: 15180330
[TBL] [Abstract][Full Text] [Related]
19. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract][Full Text] [Related]
20. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants.
Cox DS; Scott KR; Gao H; Raje S; Eddington ND
J Pharm Sci; 2001 Oct; 90(10):1540-52. PubMed ID: 11745712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
